3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
169
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Recurrence
28
Leukemia
24
Vomiting
23
Neoplasms, Plasma Cell
20
Lymphoma
18
Neoplasms
16
Nausea
13
Burkitt Lymphoma
11
Prostatic Neoplasms
8
Immunoglobulin Light-chain Amyloidosis
7
Carcinoma, Non-Small-Cell Lung
6
Lymphoma, Follicular
5
Lung Neoplasms
5
Hodgkin Disease
5
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Small Cell Lung Carcinoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Paraproteinemias
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Fallopian Tube Neoplasms
3
Interventions
Radiotherapy
8
Temozolomide
7
Lomustine
6
Procarbazine
4
Carmustine
4
Bevacizumab
4
Vincristine
3
Surgical Procedures, Operative
2
Administration, Oral
2
vorasidenib
1
fluorodopa F 18
1
contrast agent BR1
1
carmustine, poliferprosan 20 drug combination
1
Valproic Acid
1
Tranexamic Acid
1
Trabedersen
1
TIC10 compound
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation
1
Microbubbles
1
Methylphenidate
1
Methods
1
Isotretinoin
1
Infusions, Intravenous
1
IL13-PE38
1
Fentanyl
1
Eflornithine
1
Drug Delivery Systems
1
Donepezil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Glioma
×
Dexamethasone
×
Clear all
NCT06888817
2026-02-25
BRAINS
The Netherlands Cancer Institute
Phase 3
Recruiting
408 enrolled